Fenofibrate Drug Reduces the Risk of Heart Disease in Type 2 Diabetes Patients

by Madhumathi Palaniappan on  December 30, 2016 at 3:51 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Fenofibrate drug found to reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of good cholesterol, finds a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).
Fenofibrate Drug Reduces the Risk of Heart Disease in Type 2 Diabetes Patients
Fenofibrate Drug Reduces the Risk of Heart Disease in Type 2 Diabetes Patients

The research study is published in the journal JAMA Cardiology.

Fenofibrate is primarily used to help reduce elevated levels of triglycerides, or fat, in the blood. But the researchers wanted to know if the drug, when combined with statin treatment, could also reduce the risk of heart disease in people with type 2 diabetes. People with type 2 diabetes are at high risk of cardiovascular-related events, such as heart attacks, stroke, and even death, often because their levels of triglycerides are so high, and their high-density lipoprotein (HDL) cholesterol levels are low.

To answer their question, the researchers followed 4,640 participants from the NHLBI-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Study for five years after the conclusion of the trial in 2009. The findings suggest that fenofibrate therapy may be beneficial in the way the researchers hoped: by reducing cardiovascular events in patients with type 2 diabetes who take statins but still have especially high triglycerides levels and low HDL cholesterol levels. However, a randomized study is needed to confirm these findings, according to the authors.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Otitis Media Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Cardiac Catheterization Diabetes and Exercise 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...